德琪医药2024年度业绩:收入增长36.7% 亏损收窄至3.19亿元

金吾资讯
21 Mar

金吾财讯|德琪医药有限公司(股份代号:6996)发布2024年度业绩公告,报告期内实现收入9195万元,同比增长36.7%,主要得益于中国内地市场销量大幅提升。年内亏损收窄至3.19亿元,较2023年的5.81亿元减少45.1%,经调整亏损为3.05亿元,同比下降42.9%。核心财务数据:收入:9195万元(+36.7%),中国内地收入占比78.6%,韩国、马来西亚等海外市场收入增长85.7%;...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10